文献速递肾小球疾病

国际IgA肾病网络预测工具低估印度患者疾病进展

The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients.
PubMed 文献 · Kidney Int Rep · 2022-03-24

该研究在316例印度原发性IgA肾病患者中外部验证国际IgA肾病网络预测工具,中位随访2.8年发生87例主要结局事件。含与不含种族的两个模型区分度尚可(C统计量均为0.845),但在所有风险组均低估疾病进展风险,2.8年和5年校准均较差。

要点

  • 在印度IgA肾病患者中,含与不含种族的两个模型C统计量均为0.845。
  • 两个模型在所有风险组均低估疾病进展风险,2.8年和5年校准均较差。
  • 含与不含种族模型在5年和2.8年的风险重分类改善有限。

核心结论

  • 国际IgA肾病网络预测工具在印度患者中显示出尚可的风险区分度,但低估了所有风险组的疾病进展轨迹。

研究设计与样本

  • 研究为外部验证,纳入316例成年原发性IgA肾病患者,按原模型分为低、中、较高和最高风险组,中位随访2.8年。
  • 主要结局为估算肾小球滤过率(eGFR)下降超过50%或肾衰竭。

主要发现

  • 共发生87例主要结局事件。
  • 含种族与不含种族两个模型的C统计量均为0.845,R2d分别为49.9%和44.7%,生存曲线分离良好。
  • 含种族模型校准斜率为1.234(95% CI:0.973-1.494),不含种族模型为1.211(95% CI:0.954-1.468)。
  • 两个模型在预测2.8年和5年风险时校准均较差。
  • 含与不含种族模型在5年和2.8年的风险重分类改善有限。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: International IgA nephropathy (IgAN) network (IIgANN) prediction tool was developed to predict risk of progression in IgAN. We attempted to externally validate this tool in an Indian cohort because the original study did not include Indian patients. METHODS: Adult patients with primary IgAN were stratified to low, intermediate, higher, and highest risk groups, as per the original model. Primary outcome was reduction in estimated glomerular filtration rate (eGFR) by >50% or kidney failure. Both models were evaluated using discrimination: concordance statistics (C-statistics), time-dependent receiver operating characteristic (ROC) curves, R2d, Kaplan-Meier survival curves between risk groups and calibration plots. Reclassification with net reclassification improvement and integrated discrimination improvement (IDI) was used to compare the 2 models with and without race. RESULTS: A total of 316 patients with median follow-up of 2.8 years had 87 primary outcome events. Both models with and without race showed reasonable discrimination (C-statistics 0.845 for both models, R2d 49.9% and 44.7%, respectively, and well-separated survival curves) but underestimated risk of progression across all risk groups. The calibration slopes were 1.234 (95% CI: 0.973-1.494) and 1.211 (95% CI: 0.954-1.468), respectively. Both models demonstrated poor calibration for predicting risk at 2.8 and 5 years. There was limited improvement in risk reclassification risk at 5 and 2.8 years when comparing model with and without race. CONCLUSION: IIgANN prediction tool showed reasonable discrimination of risk in Indian patients but underestimated the trajectory of disease progression across all risk groups.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Bagchi S, Upadhyay AD, Barwad A, et al. The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients. Kidney Int Rep. 2022. PMID: 35685319. doi:10.1016/j.ekir.2022.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。